Topline data for the once-daily PKR activator etavopivat demonstrate a 27% reduction in vaso-occlusive crises and a robust hematologic response in patients with SCD.
A recent study in the Chinese Medical Journal reveals that circulating exosomal miR-122-3p is significantly upregulated in patients with metabolic dysfunction-associated steatotic liver disease. It ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a global public health challenge with rapidly ...
Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on ...
This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...
This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...
This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...
Nutraceutical developer launches high-concentration ginger extract designed for increased bioactivity to support joint ...
The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight The psoriasis clinical trial analysis report delivers important insights into ongoing ...
Parkinson’s disease (PD) is entering a pivotal phase. For decades, treatment has centred on dopamine replacement to manage ...
India is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results